Common Stock, Shares, Issued of Achilles Therapeutics plc from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Achilles Therapeutics plc quarterly Common Stock, Shares, Issued history and change rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Common Stock, Shares, Issued for the quarter ending 30 Jun 2024 was 41.1M shares, a 0.35% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 41.1M +142K +0.35% 30 Jun 2024 6-K 14 Aug 2024
Q4 2023 41.1M +150K +0.37% 31 Dec 2023 6-K 14 Aug 2024
Q2 2023 40.9M 30 Jun 2023 6-K 04 Aug 2023
Q4 2022 40.9M +329K +0.81% 31 Dec 2022 20-F 04 Apr 2024
Q4 2021 40.6M +36.2M +825% 31 Dec 2021 20-F 07 Mar 2023
Q4 2020 4.39M 31 Dec 2020 20-F 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.